2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$30.88+$0.86 (+2.85%)
Price as of Jun 03, 2026 4:23 PM EDT- $564.1MMarket Cap
- 47.23%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$30.88+$0.86 (+2.85%)
RIGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.02 | ||
Change | +$0.16 (+0.54%) | ||
Open | $29.38 | ||
High | $31.10 | ||
Low | $28.46 | ||
Previous Close | $29.86 | ||
Volume | 405,865 | ||
30-Day Average Volume | 449,432 | ||
1-Week Change | 2.91% | ||
1-Month Change | 2.11% | ||
1-Year Change | 47.23% | ||
3-Year Change | 114.43% | ||
5-Year Change | -20.37% | ||
Fundamentals | |||
Shares Outstanding | 18.5M | ||
Total Assets | $504.6M | ||
Market Cap | $564.1M | ||
Enterprise Value | $584.6M | ||
Period: QTR TTM FY | |||
Revenue | $54.9M | ||
Net Income | $8.7M | ||
Free Cash Flow | -$7.3M | ||
EBIT | $11.9M | ||
EBITDA | $12.5M | ||
Net Working Capital | $144.5M | ||
EPS | $0.44 | ||
Enterprise Value/EBITDA | 47 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 1 | ||
P/E | 69 | ||
PEG | -1 | ||
Price/Free Cash Flow | -78 | ||
Price/Operating Cash Flow | 207 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/27/2024 | ||
Earnings & Revenue